Form 8-K - Current report:
SEC Accession No. 0001193125-20-311859
Filing Date
2020-12-07
Accepted
2020-12-07 17:08:02
Documents
16
Period of Report
2020-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d50698d8k.htm   iXBRL 8-K 32777
2 EX-2.1 d50698dex21.htm EX-2.1 492385
3 EX-4.1 d50698dex41.htm EX-4.1 57093
4 EX-99.1 d50698dex991.htm EX-99.1 8527
8 GRAPHIC g50698g97g43.jpg GRAPHIC 2575
  Complete submission text file 0001193125-20-311859.txt   851163

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20201207.xsd EX-101.SCH 3081
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20201207_lab.xml EX-101.LAB 18138
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20201207_pre.xml EX-101.PRE 11415
9 EXTRACTED XBRL INSTANCE DOCUMENT d50698d8k_htm.xml XML 3409
Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 201373398
SIC: 2834 Pharmaceutical Preparations